NCT04941872View on ClinicalTrials.gov

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

June 24, 2022

Study Completion Date

November 1, 2022

Conditions
Tumor, Solid, FAPI, PET/CT, Metastasis
Interventions
DIAGNOSTIC_TEST

68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT

Each subject receive a single intravenous injection of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2, and undergo PET/CT imaging within the specified time.

Trial Locations (1)

361003

The First affiliated hospital of xiamen university, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER